retatrutide clinical status Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation This weight-loss drug hasn't been
Description
You developed serious side effects such as gastroparesis, pancreatitis, or intestinal blockage
prospective diabetes study 16
METHODS The authors conducted a cohort study using the TriNetX Research Network, comparing IIH patients treated with GLP-1-RAs to untreated patients, employing propensity score matching
however, it remains a consideration for any co-administered drug with a narrow therapeutic index
In a news release Thursday, the drugmaker said the oral medication, called orforglipron, helped adults lose an average of 27.3 pounds in a 72-week trial
